1764 - Micro-bypass glaucoma surgery device implantation into the suprachoroidal space as a standalone procedure in patients with open angle glaucoma

Page last updated: 27 June 2024

Application Detail

Description of Medical Service

Reduction of intraocular pressure is the only known modifiable glaucoma risk factor. Micro-bypass glaucoma surgery can be used to reduce intraocular pressure in open angle glaucoma (in patients with no current cataract co-morbidity or patients who have already undergone cataract surgery) following failure or intolerance to more conservative therapies (medication to reduce intraocular pressure and laser trabeculoplasty) when the patient is a candidate for incisional surgery. MINIject micro-bypass stent system can be inserted into the suprachoroidal space during micro-bypass surgery to enhance drainage of aqueous outflow into the suprachoroidal space to reduce intraocular pressure, reducing reliance on topical hypotensive medication.

Description of Medical Condition

Glaucoma is a group of complex eye diseases leading to chronic and progressive damage to the optic nerve and progressive, irreversible vision loss. It is a major public health problem, as glaucoma is the leading cause for irreversible visual impairment and the second leading cause for blindness worldwide. Reduction of intraocular pressure is the only known modifiable glaucoma risk factor that can reduce progressive loss of vision and is associated with improved health outcomes including reduced visual loss and improvements in quality of life.

Reason for Application

New MBS item

Medical Service Type

Therapeutic technology

Previous Application Number/s

Not applicable

Associated Documentation

Application Summary and PICO Set

Application Summary (PDF 263 KB)
Application Summary (Word 45 KB)

PICO Set (PDF 666 KB)
PICO Set (Word 218 KB)

Consultation Survey

Consultation Survey (PDF 165 KB)
Consultation Survey (Word 28 KB)

PASC Consultation
Not applicable

MSAC Consultation
MSAC consultation input closed Friday, 16 February 2024.

For further information please refer to PASC, ESC, MSAC Key Dates
For further information on the consultation process please refer to MSAC Consultation Process

PICO Confirmation


Assessment Report


Public Summary Document

Public Summary Document (PDF 761 KB)
Public Summary Document (Word 5065 KB)

Meetings for this Application


Expedited - bypassed PASC


15-16 February 2024


4-5 April 2024